-
1
-
-
0032840918
-
Human papillomavirus is a necessary cause of invasive cancer worldwide
-
Walboomers J. M. Jacobs M. V. Manos M. M. et al. Human papillomavirus is a necessary cause of invasive cancer worldwide. J Pathol 1999; 189: 12-19.
-
(1999)
J Pathol
, vol.189
, pp. 12-19
-
-
Walboomers, J.M.1
Jacobs, M.V.2
Manos, M.M.3
-
2
-
-
1542358952
-
Human papillomavirus vaccines and prevention of cervical cancer
-
Jansen K. U. Shaw A. R. Human papillomavirus vaccines and prevention of cervical cancer. Ann Rev Med 2004; 55: 319-31.
-
(2004)
Ann Rev Med
, vol.55
, pp. 319-331
-
-
Jansen, K.U.1
Shaw, A.R.2
-
3
-
-
0036221471
-
The causal relation between human papillomavirus and cervical cancer
-
Bosch F. X. Lorincz A. Muñoz N. et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-65.
-
(2002)
J Clin Pathol
, vol.55
, pp. 244-265
-
-
Bosch, F.X.1
Lorincz, A.2
Muntild3
oz, N.4
-
4
-
-
0023815225
-
Epidemiology of Genital human papillomavirus infection
-
Koutsky L. A. Galloway D. A. Holmes K. K. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988; 10: 122-63.
-
(1988)
Epidemiol Rev
, vol.10
, pp. 122-63
-
-
Koutsky, L.A.1
Galloway, D.A.2
Holmes, K.K.3
-
5
-
-
54049087444
-
-
Merck Frosst Canada Ltd. Gardasil™ (Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) 26 June (accessed Nov. 2008)
-
Merck Frosst Canada Ltd. Gardasil™ (Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) product monograph, 26 June 2007. http://www.merckfrosst.ca/mfcl/en/corporate/products/gardasil.html (accessed Nov. 2008).
-
(2007)
product monograph
-
-
-
6
-
-
65649106752
-
-
GlaxoSmithKline. Cervarix™ (Human papillomavirus (types 16, 18) product monograph, September (accessed Nov. 2008)
-
GlaxoSmithKline. Cervarix™ (Human papillomavirus (types 16, 18) recombinant adjuvanted, adsorbed vaccine) product monograph, September 2007. http://www.gsk.com (accessed Nov. 2008).
-
(2007)
recombinant adjuvanted, adsorbed vaccine)
-
-
-
7
-
-
0037242467
-
Cost effectiveness of a potential vaccine for human papillomavirus
-
Sanders G. D. Taira A. V. Cost effectiveness of a potential vaccine for Human papillomavirus. Emerg Infect Dis 2003; 9: 37-48.
-
(2003)
Emerg Infect Dis
, vol.9
, pp. 37-48
-
-
Sers, G.D.1
Taira, A.V.2
-
8
-
-
0042661252
-
Potential health and economic impact of adding human papillomavirus vaccine to screening programs
-
Kulasingam S. L. Myers E. R. Potential health and economic impact of adding human papillomavirus vaccine to screening programs. JAMA 2003; 290: 781-9.
-
(2003)
JAMA
, vol.290
, pp. 781-789
-
-
Kulasingam, S.L.1
Myers, E.R.2
-
9
-
-
2342613014
-
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
-
Goldie S. J. Kohli M. Grima D. et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 2004; 96: 604-15.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 604-615
-
-
Goldie, S.J.1
Kohli, M.2
Grima, D.3
-
10
-
-
34250827802
-
The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada
-
Brisson M. Van de Velde N. De Wals P. et al. The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine 2007; 25: 5399-408.
-
(2007)
Vaccine
, vol.25
, pp. 5399-5408
-
-
Brisson, M.1
Van De Velde, N.2
De Wals, P.3
-
11
-
-
34548301812
-
A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program
-
Kulasingam S. Connelly L. Conway E. et al. A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program. Sexual Health 2007; 4: 165-75.
-
(2007)
Sexual Health
, vol.4
, pp. 165-175
-
-
Kulasingam, S.1
Connelly, L.2
Conway, E.3
-
12
-
-
7644236858
-
Evaluating human papillomavirus vaccination programs
-
Taira A. V. Neukermans C. P. Sanders G. D. Evaluating human papillomavirus vaccination programs. Emerg Infect Dis 2004; 10: 1915-23.
-
(2004)
Emerg Infect Dis
, vol.10
, pp. 1915-1923
-
-
Taira, A.V.1
Neukermans, C.P.2
Sers, G.D.3
-
13
-
-
33846102585
-
Model for assessing human papillomavirus vaccination strategies
-
Elbasha E. H. Dasbach E. J. Insinga R. P. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis 2007; 13: 28-41.
-
(2007)
Emerg Infect Dis
, vol.13
, pp. 28-41
-
-
Elbasha, E.H.1
Dasbach, E.J.2
Insinga, R.P.3
-
14
-
-
36849068973
-
Cost-effectiveness of quadrivalent human papillomavirus
-
(HPV) in Mexico: A transmission dynamic model-based evaluation
-
Insinga R. P. Dasbach E. J. Elbasha E. H. et al. Cost-effectiveness of quadrivalent human papillomavirus (HPV) in Mexico: a transmission dynamic model-based evaluation. Vaccine 2007; 26: 128-39.
-
(2007)
Vaccine
, vol.26
, pp. 128-139
-
-
Insinga, R.P.1
Dasbach, E.J.2
Elbasha, E.H.3
-
15
-
-
35648981545
-
The value of including boys in an HPV vaccination programme: A cost-effectiveness analysis in a low-resource setting
-
Kim J. J. Andres-Beck B. Goldie S. J. The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting. Br J Cancer 2007; 97: 1322-8.
-
(2007)
Br J Cancer
, vol.97
, pp. 1322-1328
-
-
Kim, J.J.1
Andres-Beck, B.2
Goldie, S.J.3
-
16
-
-
65649152222
-
Twenty year trends
-
Kliewer E. V. Demers A. A. Elliott L. et al. Twenty year trends (1985-2004) in the incidence and prevalence of anogenital warts in Manitoba. Winnipeg: Cancercare Manitoba, 2008: 45.
-
(1985)
CancerCare Manitoba
, pp. 45
-
-
Kliewer, E.V.1
Demers, A.A.2
Elliott, L.3
-
18
-
-
65649096768
-
-
Ministry of Health Services. Medical Services Plan. Information Resource Management Branch, Knowledge Management and Technology Division. (accessed Nov
-
Ministry of Health Services. Medical Services Plan. Information Resource Management Branch, Knowledge Management and Technology Division. Ministry of Health Services.http://www.gov.bc.ca/health/ (accessed Nov. 2008).
-
(2008)
Ministry of health services
-
-
-
19
-
-
0003494060
-
Inventory of studies on the accuracy of Canadian health administrative databases
-
(publication no 96-03-TR)
-
Williams J. I. Young W. Inventory of studies on the accuracy of Canadian health administrative databases (publication no 96-03-TR). Toronto: Institute for Clinical Evaluative Sciences, 1996.
-
(1996)
Toronto: Institute for Clinical Evaluative Sciences
-
-
Williams, J.I.1
Young, W.2
-
20
-
-
65649107517
-
-
Health Protection Agency (UK). Human papillomavirus (HPV)-cervical cancer and genital warts. (accessed March
-
Health Protection Agency (UK). Human papillomavirus (HPV) -cervical cancer and genital warts. Genitourinary surveillance data, http://www.hpa.org. uk/infections/topics-az/hiv-and-sti/Stats/STIs/warts/statistics.htm (accessed 5 March 2008).
-
(2008)
Genitourinary surveillance data
, vol.5
-
-
-
22
-
-
67049140987
-
Genital warts and associated health care use in general practice in Australia
-
3-9 November
-
Conway E. L. Stein A. N. Britt H. et al. Genital warts and associated health care use in general practice in Australia. 24th International Papillomavirus Conference. 3-9 November 2007, Beijing, China [abstract]
-
(2007)
24th International Papillomavirus Conference
-
-
Conway, E.L.1
Stein, A.N.2
Britt, H.3
-
23
-
-
0038806720
-
The health and economic burden of Genital warts in a set of private health plans in the United States
-
Insinga R. P. Dasbach E. J. Myers E. R. The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis 2003; 36: 1397-403.
-
(2003)
Clin Infect Dis
, vol.36
, pp. 1397-1403
-
-
Insinga, R.P.1
Dasbach, E.J.2
Myers, E.R.3
-
24
-
-
65649092423
-
Patterns of treatment and resource utilization in the management of genital warts in Australian sexual health clinics
-
3-9 November Beijing, China [abstract]
-
Morrow A. Chuah J. Conway E. L. et al. Patterns of treatment and resource utilization in the management of genital warts in Australian sexual health clinics. 24th International Papillomavirus Conference. 3-9 November 2007, Beijing, China [abstract]
-
(2007)
24th International Papillomavirus Conference
-
-
Morrow, A.1
Chuah, J.2
Conway, E.L.3
-
25
-
-
2942542546
-
The management of sexually transmitted infections by Australian practitioners
-
Johnston V. J. Britt H. Pan Y. et al. The management of sexually transmitted infections by Australian practitioners. Sex Transm Infect 2004; 80: 212-15.
-
(2004)
Sex Transm Infect
, vol.80
, pp. 212-215
-
-
Johnston, V.J.1
Britt, H.2
Pan, Y.3
-
26
-
-
33747892746
-
Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease
-
Lacey C. J. Lowndes C. M. Shah K. V. Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24 (Suppl 3): 535-41.
-
(2006)
Vaccine
, vol.24
, Issue.3 SUPPL.
, pp. 535-541
-
-
Lacey, C.J.1
Lowndes, C.M.2
Shah, K.V.3
-
27
-
-
65649138634
-
BC Cancer Agency
-
(accessed 13 May 2008)
-
BC Cancer Agency. Cervical cancer screening programme, 2006. http://www.bccancer.bc.ca/PPI/screening/cervical (accessed 13 May 2008).
-
(2006)
Cervical cancer screening programme
-
-
-
28
-
-
41149115001
-
The validity of generic and condition-specific preference-based instruments: The ability to discriminate asthma control status
-
McTaggart-Cowan H. M. Marra C. A. Yang Y. et al. The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. Qual Life Res 2008; 17: 453-62.
-
(2008)
Qual Life Res
, vol.17
, pp. 453-462
-
-
McTaggart-Cowan, H.M.1
Marra, C.A.2
Yang, Y.3
-
29
-
-
65649098240
-
Improving osteoarthritis detection in the community: Pharmacist identification of new, diagnostically confirmed osteoarthritis
-
Marra C. A. Cibere J. Tsuyuki R. T. et al. Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis. Arthritis Rheum 2007; 15: 1238-44.
-
(2007)
Arthritis Rheum
, vol.15
, pp. 1238-1244
-
-
Marra, C.A.1
Cibere, J.2
Tsuyuki, R.T.3
|